HKU Scholars Hub: Browsing DSpace

Browsing by Author Ishikawa, T

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 7 of 7

	Title	Author(s)	Issue Date	Views
	Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET) Proceeding/Conference:ESMO (European Society for Medical On) ASIA 2018	Yap, YS Masuda, N Ito, Y Ishikawa, T Kim, SJ Aruga, T Toyama, T Saeki, T Yamanaka, T Saito, M Watanabe, J Takahashi, M Nakamura, S Inoue, K Suarez-Vizcarra, J He, W Solovieff, N Su, F Chiu, WYJ	2018	36
	Diamond nitrogen-vacancy centers created by scanning focused helium ion beam and annealing Journal:Applied Physics Letters	Huang, Z Li, W Santori, C Acosta, V Faraon, A Ishikawa, T Wu, W Winston, D Williams, R Beausoleil, R	2013	46
	Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms Journal:Nature Medicine	Bezzi, M Seitzer, N Ishikawa, T Reschke, M Chen, M Wang, G Mitchell, C Ng, C Katon, J Lunardi, A Signoretti, S Clohessy, JG Zhang, J Pandolfi, PP	2018	50
	Longitudinal circulating tumor DNA (ctDNA) analysis in the phase 1b MONALEESASIA study of ribociclib (RIB) + endocrine therapy (ET) in Asian patients (pts) with hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC) Proceeding/Conference:Annals of Oncology	Yap, YS Su, F Joshi, /M Chiu, WYJ Masuda, N Ito, Y Ishikawa, T Aruga, T Kim, SJ Deore, U Babbar, N Balbin, A	2021	13
	Ribociclib, a CDK 4/6 inhibitor, plus endocrine therapy in Asian women with advanced breast cancer Journal:Cancer Science	Yap, YS Chiu, J Ito, Y Ishikawa, T Aruga, T Kim, SJ Toyama, T Saeki, T Saito, M Gounaris, I Su, F Ji, Y Han, Y Gazdoiu, M Masuda, N	2020	30
	Title: Real-world effectiveness and safety of interferon-free DAAS for 14,676 hepatitis C (CHC) patients with genotypes 1, 2, 3, 4 and 6: a multinational study Proceeding/Conference:Poster presentation at the AASLD The Liver Meeting, November 12-15. 2021. Hepatology	Ji, F Ogawa, E Huang, C-F Toyoda, H Wong, YY Iio, E Jun, DW Liu, L Uojima, H Nozaki, A Chuma, M Tseng, C-H Hsu, .Y-C Atsukawa, M Haga, H Enomoto, M Tamori, A Trinh, HN Landis, C Lee, DH Watanabe, T Takahashi, H Abe, H Yokohama, K Asai, A Eguchi, Y Li, J Wang, XZ Li, J Liu, JP Jing, L Preda, CM Lam, C Huang, R Ye, Q Pan, HY Zhang, JJ Cai, DC Wang, Q Huang, D Wong, GLH Li, JY Kato, M Shimoda, S Furusyo, N Nakamuta, M Nomura, H Kajiwara, E Yoon, E Ahn, SB Azuma, K Dohmen, K Jung, JH Song, DS Kawano, A Koyanagi, T Ooho, A Satoh, T Takahashi, K Yeh, M-L Tsai, P-C Yasuda, S Dang, SG Li Sr., ZF Okubo, T Itokawa, N Fukunishi, S Jun, M Ishikawa, T Takaguchi, K Senoh, T Zhang, MY Zhao, CQ Tran, S Maeda, M Chuang, W-L Huang, JF Dai, C-Y Cheung, RC Buti, M Niu, JQ Xie, W Ren, H Lim, SG Wu, C Yuen, RMF Shang, J Zhu, Q Ueno, Y Tanaka, Y Hayashi, J Yu, M-L Nguyen, MH	2021
	Treatment outcome with DAAs in a multinational cohort of 11,099 hepatitis C (CHC) patients with genotypes 1, 2, 3, 4 and 6: A REAL-C study Proceeding/Conference:Hepatology International	Ji, FP Ogawa, E Huang, CF Toyoda, H Jun, DW Iio, E Nozaki, A Atsukawa, M Hsu, YC Yokohama, K Asai, A Uojima, H Watanabe, T Tseng, CH Haga, H Enomoto, M Abe, H Yasuda, S Liu, L Lee, DH Takahashi, H Ishikawa, T Li, J Liang, J Yoon, EL Ahn, SB Li, J Liu, J Senoh, T Wang, X Lam, CPM Huang, R Zhang, J Wong, G Cai, D Wang, Q Zhao, C Huang, DQ Zhang, M Furusyo, N Nakamuta, M Nomura, H Kajiwara, E Tsai, PC Yeh, ML Azuma, K Dohmen, K Jung, JH Song, DS Kato, M Kawano, A Koyanagi, T Ooho, A Satoh, T Shimoda, S Takahashi, K Dai, CY Tran, S Maeda, M Huang, JF Xu, Q Ye, Q Li, J Okubo, T Itokawa, N Jun, MJ Pan, H Dang, S Li, Z Ren, W Zhu, Q Cheung, R Niu, J Lim, SG Xie, W Ren, H Wu, C Yuen, RMF Chuang, WL Takaguchi, K Shang, J Eguchi, Y Fukunishi, S Chuma, M Tamori, A Ueno, Y Hayashi, J Tanaka, Y Yu, ML Nguyen, M	2021	19

Showing results 1 to 7 of 7